Table II.
General characteristics of the medical staff enrolled in the clinical trial.
| General characteristics | Control, N (%) | Prophylactic protocol with neutral electrolyzed water N (%) | P-value |
|---|---|---|---|
| Profession | 0.9544 | ||
| Nurses | 53 (67.1%) | 56 (66.7%) | |
| Doctors | 26 (32.9%) | 28 (33.3%) | |
| Sex | 0.7242 | ||
| Male | 22 (27.8%) | 21 (25.0%) | |
| Female | 57 (72.2%) | 63 (75.0%) | |
| Age | 40.94±7.74a | 43.73±9.01a | 0.0360b |
| 20-29 | 6 (7.6%) | 7 (8.3%) | |
| 30-39 | 29 (36.7%) | 15 (17.8%) | |
| 40-49 | 37 (46.8%) | 44 (52.4%) | 0.0081c |
| 50-59 | 5 (6.3%) | 13 (15.5%) | |
| 60-63 | 2 (2.5%) | 5 (6.0%) | |
| Comorbidities | 13 (16.5%) | 25 (29.8%) | 0.0631 |
| Obesity | 9 (11.4%) | 13 (15.5%) | |
| Diabetes | 3 (3.8%) | 5 (6.0%) | |
| Hypertension | 4 (5.1%) | 7 (8.3%) | |
| Other diseasesd | 6 (7.6%) | 7 (8.3%) |
Statistically significant values according to Student's t-test:
aAverage and standard deviation,
bP=0.05 and
cP=0.01.
dOther diseases; control group: vitiligo, obstructive sleep apnea syndrome, hypothyroidism, arthritis, irritable bowel syndrome, gastroesophageal reflux; and prophylactic protocol group: hypothyroidism, arthritis, breast cancer in remission, irritable bowel syndrome, allergic rhinitis, peripheral vascular insufficiency, arrhythmia.